CN102949684B - Medicine formula for treating rheumatoid arthritis - Google Patents

Medicine formula for treating rheumatoid arthritis Download PDF

Info

Publication number
CN102949684B
CN102949684B CN201110250094.4A CN201110250094A CN102949684B CN 102949684 B CN102949684 B CN 102949684B CN 201110250094 A CN201110250094 A CN 201110250094A CN 102949684 B CN102949684 B CN 102949684B
Authority
CN
China
Prior art keywords
radix
medicines
rhizoma
treatment
rheumatoid arthritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201110250094.4A
Other languages
Chinese (zh)
Other versions
CN102949684A (en
Inventor
张志通
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Lianzhi Pharmaceutical Technology Co ltd
Zhang Zhisheng
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201110250094.4A priority Critical patent/CN102949684B/en
Publication of CN102949684A publication Critical patent/CN102949684A/en
Application granted granted Critical
Publication of CN102949684B publication Critical patent/CN102949684B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicine formula for treating rheumatoid arthritis. The formula comprises the following components according to a unit of kilogram: 20g of sappanwood, 20g of scutellaria baicalensis, 15g of radix bupleuri, 15g of honeysuckle stem, 20g of radix clematidis, 20g of raw liquorice, 10g of cassia twig, 20g of radix paeoniae alba, 20g of rhizoma anemarrhenae, 10g of ephedra, 15g of jasmine, 8g of ginger, 30g of semen coicis, 20g of rhizoma atractylodis macrocephalae, 30g of rhizoma dioscoreae, 20g of rehmannia root, 15g of divaricate saposhnikovia root, 15g of mangnolia officinalis, 15g of parasitic loranthus and 10g of long-noded pit viper. The medicines are pulverized into 80-100 meshes of fine powder according to the proportion; the medicines are manufactured to make pills of 10g, 2 pills are orally taken for one time and three time for one day; the dosage of the medicines for 15 days is used as a first course of treatment; and the medicines are orally taken for two courses of treatment, so that the good curative effect is generally achieved.

Description

The medicament composing prescription for the treatment of rheumatoid arthritis
Affiliated technical field
The present invention relates to a kind of medicament composing prescription for the treatment of rheumatoid arthritis, i.e. a kind of medicament composing prescription that utilizes Chinese crude drug treatment rheumatoid arthritis.
Background technology
Rheumatoid arthritis belongs to the category of motherland's medical science pyretic arthralgia, and it is how obstructed in meridians, joint, QI and blood stasis by wind, wet, all evil harmonies of heat that ancients think, so that local red and swollen scorching hot, and arthralgia can not be bent and stretched and ill.Modern medicine is thought: it is that the struvite autoimmune disease of chronic systematicness that synovium of joint is main target tissue is take in a kind of infringement.The main little joint of brothers of invading, other organ or tissue also can get involved, and this disease does not have good drug treatment at present, and patient can not walk, very painful.
Summary of the invention
In order to cure this disease, alleviate patient suffering, the invention provides a kind of medicament composing prescription of highly effective treatment rheumatoid arthritis.
Plan method for the treatment of of the present invention is: expelling wind and removing dampness, warming the meridian a surname numbness, nourishing YIN and clearing away heat.
Prescription of the present invention is (in grams): Lignum Sappan 20, Radix Scutellariae 20, Radix Bupleuri 15, Caulis Lonicerae 15, Radix Clematidis 20, Radix Glycyrrhizae 20, Ramulus Cinnamomi 10, the Radix Paeoniae Alba 20, the Rhizoma Anemarrhenae 20, Herba Ephedrae 10, Fructus Gardeniae 15, Rhizoma Zingiberis Recens 8, SEMEN COICIS 30, the Rhizoma Atractylodis Macrocephalae 20, Rhizoma Dioscoreae 30, the Radix Rehmanniae 20, Radix Saposhnikoviae 15, Cortex Magnoliae Officinalis 15, Herba Taxilli 15, Agkistrodon 10.
Said medicine is mixed in proportion and is pulverized as 80-100 object smalls, make the pill of 10 grammes per square metres, 2 balls, take for three times on the one, within 15 days, are a course for the treatment of, take 2 courses for the treatment of, can receive good curative effect.
In side: Lignum Sappan, Radix Clematidis, Ramulus Cinnamomi, Herba Ephedrae, Agkistrodon all have dredge the meridian passage, the effect of activating stagnated YANG, wherein, Lignum Sappan has immunosuppressive action according to modern study.Radix Bupleuri depressed liver-energy dispersing and QI regulating, the Cortex Magnoliae Officinalis circulation of qi promoting painful abdominal mass that disappears; The Rhizoma Atractylodis Macrocephalae, Rhizoma Dioscoreae strengthening spleen, tonifying kidney; Radix Saposhnikoviae, Herba Taxilli expelling wind and removing dampness; SEMEN COICIS promoting diuresis to eliminate damp pathogen; Rhizoma Zingiberis Recens warming middle-JIAO to arrest vomiting; The Rhizoma Atractylodis Macrocephalae, the Rhizoma Anemarrhenae, Radix Rehmanniae nourishing YIN and clearing away heat; Radix Scutellariae, Radix Glycyrrhizae, Fructus Gardeniae clearing away heat-fire reason wet, and wherein, Radix Scutellariae, Radix Glycyrrhizae all have immunosuppressive action according to modern study.
This beneficial effect of the invention is: utilize the Chinese herbal medicine of motherland's traditional medicine to carry out reasonable compatibility, treatment cost is lower, and side effect is less, and therapeutic effect is remarkable.
The specific embodiment
The effectiveness of said medicine is now described with 60 routine patients of clinical observation, 60 routine patients are completely with reference to the Americanism damp disease RA of association in 1987 diagnostic criteria, get rid of Liver and kidney patient, hypertension, diabetes, Peptic Ulcers and the medicine factor that affects the treatment and observe, wherein, male 36 examples, female's 24 examples, the shortest person of the course of disease 1 year, elder 20 years, patient, by 2 balls of said medicine, takes for three times on the one, take 2 courses for the treatment of, in 60 routine patients, cure 19 examples as a result, effective 23 examples, 15 examples take a turn for the better, invalid 3 examples, total effective rate 95%.

Claims (1)

1. a medicine for the treatment of rheumatoid arthritis, it is characterized in that described medicine made by the crude drug of following weight portion: Lignum Sappan 20, Radix Scutellariae 20, Radix Bupleuri 15, Caulis Lonicerae 15, Radix Clematidis 20, Radix Glycyrrhizae 20, Ramulus Cinnamomi 10, the Radix Paeoniae Alba 20, the Rhizoma Anemarrhenae 20, Herba Ephedrae 10, Fructus Gardeniae 15, Rhizoma Zingiberis Recens 8, SEMEN COICIS 30, the Rhizoma Atractylodis Macrocephalae 20, Rhizoma Dioscoreae 30, the Radix Rehmanniae 20, Radix Saposhnikoviae 15, Cortex Magnoliae Officinalis 15, Herba Taxilli 15, Agkistrodon 10, above-mentioned raw materials medicine is mixed in proportion and is pulverized as 80-100 object smalls, make the pill of 10 grammes per square metres.
CN201110250094.4A 2011-08-18 2011-08-18 Medicine formula for treating rheumatoid arthritis Expired - Fee Related CN102949684B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201110250094.4A CN102949684B (en) 2011-08-18 2011-08-18 Medicine formula for treating rheumatoid arthritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110250094.4A CN102949684B (en) 2011-08-18 2011-08-18 Medicine formula for treating rheumatoid arthritis

Publications (2)

Publication Number Publication Date
CN102949684A CN102949684A (en) 2013-03-06
CN102949684B true CN102949684B (en) 2014-04-02

Family

ID=47759444

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201110250094.4A Expired - Fee Related CN102949684B (en) 2011-08-18 2011-08-18 Medicine formula for treating rheumatoid arthritis

Country Status (1)

Country Link
CN (1) CN102949684B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105833117A (en) * 2016-05-17 2016-08-10 刘喜德 Traditional Chinese medicine composition for treating rheumatoid arthritis

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101357168A (en) * 2008-09-16 2009-02-04 朱惠芬 Medicinal wine for treating rheumatic arthritis
CN101496849A (en) * 2008-01-31 2009-08-05 邹方昕 Chinese medicine preparation for treating atrophic arthritis
CN101543620A (en) * 2008-03-28 2009-09-30 北京汉潮大成科技孵化器有限公司 Traditional Chinese medicine preparation for treating rheumatoid arthritis
CN101829312A (en) * 2010-05-18 2010-09-15 山西省屯留县科技情报服务中心 Medicament for treating rheumatoid arthritis and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101496849A (en) * 2008-01-31 2009-08-05 邹方昕 Chinese medicine preparation for treating atrophic arthritis
CN101543620A (en) * 2008-03-28 2009-09-30 北京汉潮大成科技孵化器有限公司 Traditional Chinese medicine preparation for treating rheumatoid arthritis
CN101357168A (en) * 2008-09-16 2009-02-04 朱惠芬 Medicinal wine for treating rheumatic arthritis
CN101829312A (en) * 2010-05-18 2010-09-15 山西省屯留县科技情报服务中心 Medicament for treating rheumatoid arthritis and preparation method thereof

Also Published As

Publication number Publication date
CN102949684A (en) 2013-03-06

Similar Documents

Publication Publication Date Title
CN101129595A (en) Traditional Chinese medicine for treating lumbago due to kidney deficiency
CN103341004B (en) Chinese medicine composition for treating delayed menstrual cycle
CN103316174B (en) Traditional Chinese medicinal composition for treating acute cholecystitis and preparation method thereof
CN103705866A (en) Traditional Chinese medicine composition for treating hypomenorrhea
CN103272096A (en) Traditional Chinese medicine for treating dysmenorrhea
CN103751562A (en) Traditional Chinese medicine for treating calculus
CN101690768B (en) Vein and artery relieving pills for impediment of sinew
CN103705849A (en) Traditional Chinese medicine for treating bronchial asthma
CN1994453B (en) Orally administered Chinese medicine for treating dysmenorrheal caused by qi stagnation and blood stasis
CN102274466B (en) Chinese medicinal composition for treating gastritis
CN101284113A (en) Yin toxin Qingyuan pellet
CN103127351B (en) Traditional Chinese medicine for treating premature menstruation
CN1320914C (en) Menstruation regulating powder
CN102416145A (en) Chinese medicinal composition for treating menstrual disorder
CN101897930A (en) Chinese medicinal herb for treating dysmenorrhoea disease
CN102949684B (en) Medicine formula for treating rheumatoid arthritis
CN101991797A (en) Medicine formula for treating Behcet's disease
CN101757206A (en) Chinese medicine preparation for treating chronic colitis
CN104173818A (en) Traditional Chinese medicine composition for treating calculus
CN103721082A (en) Traditional Chinese medicinal composition for treating scapulohumeral periarthritis
CN101130003A (en) Traditional Chinese medicine for treating acute cholecystitis
CN104523965A (en) Nephritis treating traditional Chinese medicine composition
CN104667243A (en) Traditional Chinese medicament for treating ulcerative colitis
CN102397403A (en) Medicine for treating kidney dysfunction
CN101152394A (en) Traditional Chinese medicine for treating chronic active hepatitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CP03 Change of name, title or address

Address after: 734200 No.11, group 9, kangzhai village, Xinhua Town, Linze County, Zhangye City, Gansu Province

Patentee after: Zhang Zhisheng

Address before: 734200 Linze County, Gansu Province, Xinhua Township, Kang Village 9 Club

Patentee before: Zhang Zhitong

CP03 Change of name, title or address
TR01 Transfer of patent right

Effective date of registration: 20210416

Address after: Lianhuan pharmaceutical, building E5, Jiangsu life science and Technology Innovation Park, No.9, Weidi Road, Xianlin street, Qixia District, Nanjing City, Jiangsu Province

Patentee after: Nanjing Lianzhi Pharmaceutical Technology Co.,Ltd.

Address before: 734200 No.11, group 9, kangzhai village, Xinhua Town, Linze County, Zhangye City, Gansu Province

Patentee before: Zhang Zhisheng

TR01 Transfer of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140402

CF01 Termination of patent right due to non-payment of annual fee